Cargando…
Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series
OBJECTIVE: Combination biological therapies are being considered increasingly for patients with multiple co-morbidities requiring biologics. There are limited data available on this approach, and concerns remain about the possible risk of adverse events, particularly infection. METHODS: We present t...
Autores principales: | Malik, Mariam, Jones, Bryony, Williams, Emma, Kurukulaaratchy, Ramesh, Holroyd, Chris, Mason, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923700/ https://www.ncbi.nlm.nih.gov/pubmed/36789243 http://dx.doi.org/10.1093/rap/rkad018 |
Ejemplares similares
-
Minimal Difference in the Prevalence of Asthma in the Urban and Rural Environment
por: Malik, Hamood Ur-Rehman, et al.
Publicado: (2012) -
Paradoxical eczema in patients with psoriasis receiving biologics: a case series
por: Al‐Janabi, Ali, et al.
Publicado: (2022) -
Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Singh, Dilpreet K, et al.
Publicado: (2019) -
How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID‐19
por: Décary, Simon, et al.
Publicado: (2020) -
Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021)